Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Xingxing Technology Pharmaceutical is a pharmaceutical manufacturing enterprise located in Meihekou City, Jilin Province, China. Established in 1998, the company focuses on the production of traditional Chinese medicines (TCM) and chemical pharmaceuticals across various dosage forms, including capsules, tablets, and granules. Its commercial portfolio features widely used treatments for respiratory conditions, such as Yinhuang capsules and compound paracetamol/amantadine hydrochloride. The company maintains GMP-certified facilities and primarily targets the domestic Chinese market through a broad distribution network. It is recognized as a high-tech enterprise within its region and contributes significantly to the local pharmaceutical industrial cluster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Xingxing Technology Pharmaceutical.